How to Buy Solventum Stock
Solventum Corp
Solventum is a health information service company located in Minnesota, United States, which is part of the Healthcare sector, and is traded under the ticker SOLV on the NYSE exchange.
Solventum stock last closed at $74.07, down 0.08% from the previous day, and has increased 2.41% in one year. It has overperformed other stocks in the Health Information Services industry by 0.56 percentage points. Solventum stock is currently +22.03% from its 52-week low of $60.70, and -13.79% from its 52-week high of $85.92.
There are currently 173.01M shares of SOLV outstanding. The market cap of SOLV is $12.82B. In the past 24 hours, 1.71M SOLV shares were traded.
How to Buy Solventum Stock
Not sure how to invest in Solventum stock? Here's how.
- Decide where to buy Solventum stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you choose where to buy Solventum stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Choose your method of payment and add your information.
- Analyze Solventum stock: The Solventum ticker symbol is SOLV. Is Solventum stock a good investment? Should you buy shares of SOLV? How do SOLV's underlying business fundamentals look? Do top analysts think Solventum is a good buy? Why has SOLV's stock price moved recently? (Hint: Our stock market research website can help you evaluate if SOLV is a good stock to buy).
- Place your SOLV buy order: Decide if you will purchase SOLV shares at the current market price or use a limit order to purchase SOLV shares at a given price.
- Track your SOLV investment: Create a watchlist to get live updates on your investment in Solventum stock.
Step 1: Decide where to buy Solventum stock
You need a brokerage account to access the NYSE market and buy SOLV stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal details so you can buy SOLV today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open a new trading account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have finished signing up on the best stock market app for beginners, your next step is to transfer the money for your investment:
Watch the walkthrough below to see the process of transferring funds into your brokerage account.
Step 4: Analyze Solventum stock
Once you have decided on the best place to buy Solventum stock, it's important to evaluate their stock prior to buying, so you can understand the risk and upside.
Solventum Numbers
SOLV Due Diligence Score
WallStreetZen was designed to help average investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on SOLV's stock page.
How is SOLV stock valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SOLV's true value.
Using relative valuations metrics:
- SOLV may be undervalued based on its P/E ratio of 33.98x, relative to Health Information Services industry P/E ratio of 85.39x
- SOLV may be undervalued based on its P/B ratio of 3.93x, relative to Health Information Services industry P/B ratio of 4.12x
- SOLV may be undervalued based on its PEG ratio of 0.74x
You can do additional valuation research on SOLV's stock here.
SOLV Financial Health
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the SOLV balance sheet.
Failed Financial Due Diligence Checks:
- SOLV earnings of $747.00M is not sufficient to cover its interest payments.
- There are more long-term liabilities than short-term assets on the SOLV balance sheet.
- SOLV has a relatively high debt to equity ratio of 3.45.
- SOLV profit margin has gone down from 15.7% to 4.6% in the past year.
- SOLV's operating cash flow of $772.00M allows it to safely service it's debt of $7.91B.
Do analysts think it's a good time to buy SOLV stock
Out of 4 Equities analysts who monitor SOLV, the consensus analyst rating on Solventum is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Solventum stock forecast page.
Metrics for Advanced SOLV Traders
SOLV Performance Numbers
Last year, SOLV earnings were $379.00M. In the last one years, SOLV's earnings have grown by -70.78% per year. This was slower than the Health Information Services industry average of 15.78%.
Last year, SOLV revenue was $8.31B. During the past 1 years, SOLV's revenue has gone up by 1.29% per year. This was slower than the Health Information Services industry average of 24.53%.
You can research SOLV's earnings and revenue performance here.
What are SOLV executives and large shareholders up to?
Over the past 12 months, insiders at SOLV have sold more shares than they have bought.
Bryan C. Hanson, Chief Executive Officer of SOLV, was the latest SOLV insider to sell. They sold $1,934,546.12 worth of SOLV stock on Sep 1, 2025.
Learn more about who owns SOLV stock here.
Can I get consistent income from SOLV stock?
No, Solventum doesn't provide an income stream by paying out dividends.
What others are saying about SOLV
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your SOLV buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount, use a limit order.
Press the Open Trade button and your broker will execute your order.
If you want additional assistance buying stocks on eToro, click the helpful video below:
Step 6: Track your SOLV investment
Now that you own some SOLV stock, you'll want to stay up-to-date on your new company.
Make a watchlist to track your SOLV stock.
SOLV Feed
How to Buy Stock in Solventum
To summarize, here are the 6 steps for buying Solventum stock:
- Decide where to buy Solventum stock
- Sign up for a brokerage account
- Put funds into your investment account
- Analyze Solventum stock
- Place your SOLV buy order
- Track your SOLV investment
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Solventum, add SOLV to your watchlist by clicking the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.